Oldest pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #491 to #540.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Α/β value (21:46, 24 February 2021)
- ΓH2AX foci (21:46, 24 February 2021)
- Informed consent (21:49, 24 February 2021)
- Supervised area (21:51, 24 February 2021)
- Access control (21:52, 24 February 2021)
- Acute exposure (21:54, 24 February 2021)
- Adventitious source (21:55, 24 February 2021)
- Authorised discharge (21:57, 24 February 2021)
- Backscatter factor (21:59, 24 February 2021)
- Best available techniques (22:00, 24 February 2021)
- Disposal facility (22:02, 24 February 2021)
- Dose modifying factor (22:03, 24 February 2021)
- Exposure pathway (22:05, 24 February 2021)
- Radiological controlled area (22:07, 24 February 2021)
- Life Span Study (22:10, 24 February 2021)
- Detriment (19:17, 25 February 2021)
- Baseline disease rates (19:29, 25 February 2021)
- Biomarker (19:31, 25 February 2021)
- Case–control study (19:33, 25 February 2021)
- Deterministic effect (19:38, 25 February 2021)
- Dose and dose-rate effectiveness factor (15:54, 26 February 2021)
- Dose-threshold hypothesis (15:56, 26 February 2021)
- Tissue reaction (16:00, 26 February 2021)
- Doubling dose (17:10, 26 February 2021)
- Epigenetic effects (17:13, 26 February 2021)
- Excess absolute risk (17:16, 26 February 2021)
- Excess relative risk (17:25, 26 February 2021)
- Homologous recombination (17:26, 26 February 2021)
- Incidence (17:28, 26 February 2021)
- Induced genomic instability (17:30, 26 February 2021)
- Late normal tissue responses (17:31, 26 February 2021)
- LD 50/30 (17:33, 26 February 2021)
- Lifetime risk estimates (17:42, 26 February 2021)
- Linear dose response (17:43, 26 February 2021)
- Linear-quadratic dose response model (17:48, 26 February 2021)
- Stochastic effect (17:58, 26 February 2021)
- Nominal risk coefficient (19:29, 26 February 2021)
- Non-homologous end joining (19:30, 26 February 2021)
- Non-targeted effects (19:31, 26 February 2021)
- Normal tissue complication probability (19:33, 26 February 2021)
- Pooled analysis (19:34, 26 February 2021)
- Quasi-threshold dose (19:35, 26 February 2021)
- Reactive oxygen species (19:36, 26 February 2021)
- Recovery (cellular or tissue) (19:38, 26 February 2021)
- Reference Animal and Plant (19:43, 26 February 2021)
- Relative biological effectiveness (20:22, 26 February 2021)
- Relative risk (20:25, 26 February 2021)
- Risk coefficient (20:30, 26 February 2021)
- Targeted effects (20:32, 26 February 2021)
- Translocation (20:33, 26 February 2021)
